Tuesday, December 7, 2021

The Morning: Omicron Q&A

Four big questions, and experts' answers.

Good morning. We answer four big questions about Omicron.

A vaccination site in Johannesburg.Joao Silva/The New York Times

Knowns and unknowns

Scientists around the world are racing to understand the Omicron variant, and there are some clearer signs than a week ago.

Today's newsletter will try to answer four big questions about Omicron, with help from experts. The answers do come with a caveat: There is still a lot of uncertainty about almost every aspect of the variant. As scientists learn more, I'll continue to update you.

1. Contagiousness

Does Omicron spread faster than earlier variants? Yes, in all likelihood.

The number of Covid cases is soaring in South Africa, for example. It's still possible that this will be a mirage — and that the world is confusing a more normal surge in cases with the effects of a new variant. (Surges do often happen for mysterious reasons.) But the evidence for faster spread of Omicron seems strong.

"The data out of South Africa suggest that the Omicron variant is spreading more quickly than Delta," Janet Baseman, an epidemiologist at the University of Washington, told me. Dr. Rebecca Wurtz of the University of Minnesota said, "Omicron is more contagious."

A bigger unknown is why it's spreading rapidly, and there are two plausible answers. The first is that Omicron is more contagious in a technical sense — that it spreads more rapidly among people with no immunity than earlier variants did. The second is known as immune evasion; it describes the notion that vaccinated people and those who were previously infected contract Omicron more often than they contracted earlier versions of the virus.

Both explanations could be true, and many scientists think they probably both are. But the facts are not clear, and one of the two explanations may turn out to be much more significant than the other. "Bottom line: Not much doubt that Omicron spreads faster than Delta; we're still not 100 percent sure why," Dr. Robert Wachter of the University of California, San Francisco, told me.

2. Severity

Is Omicron more severe than earlier variants? Probably not. But there is less consensus on this than the first question.

Some scientists think it's simply too early to know whether the average person who contracts Omicron becomes sicker than the average person who contracted earlier versions of the Covid virus. "It's all speculation at this point," Dr. Paul Sax of Brigham and Women's Hospital in Boston told me.

Severe Covid illness often takes a week or more to develop, and the world has been aware of Omicron for less than two weeks. "We may just not have had enough time to see severe disease develop," Dr. Aaron Richterman of the University of Pennsylvania said. The initial studies of Omicron patients have also come disproportionately from South Africa, where the population skews young and many people were previously infected with Delta. Both groups are unlikely to get very sick.

"What is hard to assess right now," Jennifer Nuzzo of Johns Hopkins University said, "is how this will play out if or when older and more vulnerable people become infected."

But other scientists believe that the early signs are clearer and more positive. If anything, they say, Omicron may be milder than previous variants. Hospitalization and death rates in South Africa have not soared even as cases have. Intriguingly, patients are reporting less loss of taste and smell.

Dr. David Dowdy, another Johns Hopkins epidemiologist, told me that he happened to have a close research collaboration with scientists in Tshwane, a South African city at the epicenter of the outbreak. His colleagues there have told him that hospitalizations and oxygen demand are lower than during previous waves. "I think the signs are actually extremely optimistic," he said.

You'll hear some similar messages in these Bloomberg interviews with South African scientists. "It's early days, but I'm less panicked," said Richard Friedland, the chief executive of the country's largest network of private health care providers. "It feels different to me on the ground."

Either way, I think it's a mistake to assume that Omicron is more severe than earlier versions of the virus — as people often do when they hear about a new variant. "Thus far, the signals are a bit encouraging regarding the severity," Dr. Anthony Fauci said this weekend on CNN.

3. Risks to the vaccinated

So are vaccinated people protected or not? The answer depends on the meaning of "protected." Is it protected from any Covid infection — or from severe illness?

The evidence so far suggests that Omicron may be more likely to infect vaccinated people than earlier versions of the virus, as I mentioned above. Yet there is still no sign that Omicron will cause a significant share of vaccinated people to get severe versions of Covid.

"I do think vaccines will hold up, not so much for getting infections but for severe illness," Dr. Eric Topol of Scripps Research told me. Dowdy, of Johns Hopkins, put it this way: "Our immune systems are designed to protect us from getting sick, not from getting any infection whatsoever."

The situation may be similar for unvaccinated people who have had a prior infection — or they may be more vulnerable than the vaccinated to serious Covid. It's not clear.

One worrisome postscript is that even seemingly mild Covid infections can prove deadly for vulnerable people, like the elderly. The flu kills large numbers of elderly people for the same reason.

A second problem is that immunity among the vaccinated and previously infected really does seem to be waning over time. "Our effective vaccination rate is dropping" because of waning immunity, Topol noted.

All of this argues for getting vaccinated, even if you have been infected, and getting boosted, if you're eligible. "People need to be told to get boosted now and not wait the three to four months for a specific Omicron vaccine," Wachter said.

4. Tests

Do Covid tests — including both PCR tests and rapid at-home tests — still work? Yes, based on the signs so far.

Assuming that remains true, it will be very helpful. "Omicron's spread will put a much greater premium on rapid testing, as will the new oral drugs," Wachter said.

Bottom line

The early signs may prove misleading, and we will know more within a few weeks.

For now, vaccinated people can reasonably continue to behave as they were — but many should feel urgency about getting booster shots. Older people and others who are vulnerable, like people receiving cancer treatment, should continue to be careful and ask people around them to test frequently.

Unvaccinated people remain at substantial risk of serious illness. About 1,000 Americans have been dying each day of Covid in recent weeks, the vast majority of them unvaccinated.

More virus news:

THE LATEST NEWS

U.S.-Russia Relations
  • President Biden will meet with Vladimir Putin by video today to discuss tensions at the Russia-Ukraine border.
  • Biden will warn Putin that if Russia invades, the West may move to cut it off from the international financial system.
  • Life on the front: Dodging bullets and grenades, and waiting for the invasion.
  • What's driving Putin's brinkmanship?
Politics
Preparations at the ski jumping center in Zhangjiakou, China.Andrea Verdelli/Getty Images
Other Big Stories
Opinions

Erika Bachiochi didn't vote for Trump. But with the Supreme Court poised to overturn Roe v. Wade, she's grateful to those who did.

"We don't turn into aliens." Five teen girls talk about the trials of growing up, including period pains and catcalling.

Deeply reported journalism needs your support.

The Times relies on subscribers to help fund our mission. Become a subscriber today.

ADVERTISEMENT

MORNING READS

The recruits came from a pool of 12,000 applicants.Thomas Shea/Agence France-Presse — Getty Images

Stars: Meet NASA's next astronauts.

Sticker shock: Chanel, TikTok and the $825 Advent calendar.

Inside Tesla: How Elon Musk pushed an unflinching vision for self-driving cars.

Health: After prostate cancer treatment, gay and bisexual men need a different kind of support.

Advice from Wirecutter: Winter picks for running gear, warm bedding and snow blowers.

Lives Lived: Fred Hiatt, the longtime leader of The Washington Post's opinion section, used his position to support justice and human rights. He died at 66.

ARTS AND IDEAS

Alana Haim has surprised everyone with her movie debut.Josefina Santos for The New York Times

A sparkling screen debut

When Alana Haim opened an email from the director Paul Thomas Anderson and saw a script with a character named "Alana," she was flattered that he planned to use her name in a movie, she told The Times's Lindsay Zoladz. In fact, Anderson was asking Haim — one of three sisters from the rock band bearing their surname — to star in his next film, "Licorice Pizza." She took the job — her first movie — and critics are praising her performance.

PLAY, WATCH, EAT

What to Cook
Johnny Miller for The New York Times

Andouille sausage, white beans and collard greens are not typically used in pasta, but this dish may become part of your regular rotation.

What to Read

"The Anomaly," by Hervé Le Tellier, is about the mysterious fate of a flight from Paris to New York.

What to Watch

At the Met Opera, Sondra Radvanovsky and Brian Jagde sing thrillingly, and Yannick Nézet-Séguin conducts a superb performance of the Puccini classic "Tosca," Anthony Tommasini writes.

Late Night
Now Time to Play

The pangram from yesterday's Spelling Bee was windmilled. Here is today's puzzle — or you can play online.

Here's today's Mini Crossword, and a clue: Abate (five letters).

If you're in the mood to play more, find all our games here.

Thanks for spending part of your morning with The Times. See you tomorrow. — David

P.S. Ellen Barry, a Pulitzer Prize-winning Times correspondent, is joining the Science desk to report on mental health.

"The Daily" is about prosecuting school shootings. On "The Ezra Klein Show," Ai-jen Poo discusses America's child care and elder care crisis.

Claire Moses, Ian Prasad Philbrick, Tom Wright-Piersanti, Ashley Wu and Sanam Yar contributed to The Morning. You can reach the team at themorning@nytimes.com.

Need help? Review our newsletter help page or contact us for assistance.

You received this email because you signed up for the Morning newsletter from The New York Times, or as part of your New York Times account.

To stop receiving these emails, unsubscribe or manage your email preferences.

Subscribe to The Times

Connect with us on:

facebooktwitterinstagram

Change Your EmailPrivacy PolicyContact UsCalifornia Notices

LiveIntent LogoAdChoices Logo

The New York Times Company. 620 Eighth Avenue New York, NY 10018

No comments:

Post a Comment